Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

The vast majority of retail client accounts lose money when trading CFDs.

You should consider whether you can afford to take the high risk of losing your money.

Important Notice - Fraud awareness
Important Notice - Scam alert
54.76% of retail investor accounts lose money when trading CFDs / Spread betting with this provider.
Important Notice - Fraud awareness
Important Notice - Scam alert
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 54.76% of retail investor accounts lose money when trading CFDs / Spread betting with this provider. You should consider whether you understand how CFDs / Spread betting work and whether you can afford to take the high risk of losing your money.
Important Notice - Fraud awareness
Important Notice - Scam alert
The vast majority of retail investor accounts lose money when trading CFDs / Spread betting with this provider.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The vast majority of retail investor accounts lose money when trading CFDs / Spread betting with this provider. You should consider whether you understand how CFDs / Spread betting work and whether you can afford to take the high risk of losing your money.
ATFX

FCA License No: 760555

Language
    ATFX-search-icon
    Client Portal
    Start trading
    rch

    CVS share price forecast to respond to another earnings beat

    CVS Health is a classic example of a company which illustrates the merits of strictly trading or investing according to the strict merits of the actual reported fundamentals, rather than the CVS share price trading by market sentiment alone.

    Of course, in the current pandemic environment sentiment is even more inconsistent, and arguably now downright jittery, than the actual fundamentals of the pharmacy. An illustration of the divergence between reality of the CVS share price and sentiment is shown by the way the company has not only beaten earnings estimates on each of the last four occasions, yet the market still behaves as if it is looking down the steepest of binary cliffs edges.

     

     

    Earnings surprises continues at CVS Health

    Although it might be believed that even though CVS Health has offered up earnings surprises of an average of 15% both pre and post the pandemic, investors could be more charitable towards the CVS share price, as we approach the November 6 Q3 update from the group, we seem to have the same reticence revealing itself. Indeed, at the end of October the CVS share price dipped to $3 of their March floor at $52.04 intraday – a key level for most equity related stocks and markets. 

     

    The CVS Health enigma

    However, what remains something of an enigma for both bulls and bears of the CVS share price is the way that the company has a market cap of $76bn, net debt of $74.5bn and total debt of $92bn. This total debt figure is clearly a problem, especially for those looking for value, and even though the full year revenue stands at $256bn. All of this suggests that especially in the present volatile environment, it would not take too much to go wrong for the financial wheels to come off the wagon at CVS Health.

     

    Mixed newsflow

    Coincidentally, if some of the key financial metrics at CVS Health are offering mixed signals, the same could be argued as far as the newsflow in recent months, especially since the start of the COVID-19 crisis. Clearly, there has been a negative impact from initial 2020 disruption to walk-in clinics and patient visits, as well as higher labour costs and reduced disposable income.

     

    Nevertheless, the rest of the tide appears to be running in CVS Health’s favour as far as fundamental factors – particularly initiatives to free up hospital beds and provide as much diagnosis, treatment and care at home.

     

    The US Government boost to the CVS Health share price

    The highlight in this respect has ironically been the latest significant piece of news – the US Government signing up the major pharmacies including CVX to serve as COVID-19 vaccination sites.

    Ordinarily, one would have expect such a serious development to be transformational in terms of sentiment towards the CVS share price and any CVS share price forecast, especially as it was combined with news just a couple of days previously that CVS Health plans to expand rapid-result COVID-19 testing to nearly 1,000 sites by year-end, having administered more than 5 million COVID-19 tests since March.

     

    How to trade shares with ATFX

    Looking to trade CVS shares and other major company shares? Open a live or demo account with ATFX to get up to speed. Start trading now to benefit from competitive spreads, high-quality trade execution, and no commission.

    1. Register for an account or log in to your existing account

    2. Open MT4 either on your desktop or mobile

    3. Search for CVS shares in the market watch or symbols window

    4. Choose your position size

    5. Hit buy or sell, and then confirm the trade

     

    CVS Health share price: Q3 consensus earnings upgrade

    Interestingly, the best of the good news of late actually came in after a major consensus earning upgrade for Q3. This consisted of a Q3 earnings upgrade from $1.32 to $1.75 per share for the CVS share price, with the full year number raised to $9.50 per share from $7.23.

    All of this, along with investors of late being overly pessimistic in their attitude to the CVS share price and earnings suggest that the divergence between expectation and reality could be as great as ever. This is especially so given the cautious added to the equation by the aftermath of the US Presidential election and potential plans to lower drugs cost, and tip the sector in favour of the consumer due to the pandemic.

     

    Daily chart showing CVS share price daily movements for 2020

     

    Looking for a great trading platform, look no further. MetaTrader 4 is the world's most popular trading platform for a reason. 

    It offers a host of functionality that will boost your trading experience. From advanced indicators to automatic trading as well as alerts and trade signals.

    Last Updated: 03/11/2020

    This market commentary and analysis has been prepared for ATFX by a third party for general information purposes only. Any view expressed does not constitute a personal recommendation or solicitation to buy or sell as it does not take into account your personal circumstances or objectives, and should therefore not be interpreted as financial, investment or other advice, or relied upon as such. You should therefore seek independent advice before making any investment decisions. This information has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. We aim to establish and maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. The market data is derived from independent sources believed to be reliable, however we make no representation or warranty of its accuracy or completeness, and accept no responsibility for any consequence of its use by recipients. Reproduction of this information, in whole or in part, is not permitted.


     

    Recent news

    Recent news
    GBPUSD turns bearish ahead of GDP report

    GBPUSD started the week at $1.227, and has fully reversed its bullish trend. The bulls qui...

    Recent news
    Gold (XAUUSD) prices face rejection at $1807

    The precious metal gold faced some rejection after reaching $1,807 on Wednesday, following...

    Recent news
    US dollar slides downwards amidst July CPI cool down

    July's Consumer Price Index (CPI) came out lower. The US dollar dominance in the forex mar...

    Recent news
    Bitcoin prices jump above $24K as US inflation cools down

    The crypto market witnessed a strong bounce yesterday. Bitcoin (BTCUSD) prices led the way...

    Recent news
    USDCAD holds above $1.2884 as market awaits for US CPI

    USDCAD has sustained above its support level of $1.2884 from yesterday. The price is seen ...